Pregnancy Outcomes After Second-Generation Antipsychotic Exposure: Extracting More Information From the Data
J Clin Psychiatry
.
2022 Nov 30;84(1):22lr14594.
doi: 10.4088/JCP.22lr14594.
Authors
Malathi Perugula
1
2
,
Ramu Vadukapuram
3
,
Chintan Trivedi
4
,
Darakhshan Adam
5
,
Zeeshan Mansuri
6
7
,
Shailesh Jain
4
7
Affiliations
1
Department of Psychopharmacology, Manhattan Psychiatric Center, Nathan Kline Institute, New York, New York.
2
Corresponding author: Malathi Perugula, MD, 197 Liberty Ave, Apt 2, Jersey City, NJ 07306 (dr.malathiperugula@gmail.com).
3
Department of Psychiatry, The University of Texas Rio Grande Valley, Harlingen, Texas.
4
Department of Psychiatry, Texas Tech University Health Science Center at Odessa/Permian Basin Odessa, Midland, Texas.
5
Allen Psychiatry, Allen, Texas.
6
Department of Psychiatry, Boston Children's Hospital/ Harvard Medical School, Boston, Massachusetts.
7
Drs Jain and Mansuri share equal credit for senior authorship.
PMID:
36449477
DOI:
10.4088/JCP.22lr14594
No abstract available
Publication types
Letter
Comment
MeSH terms
Antipsychotic Agents* / adverse effects
Female
Humans
Pregnancy
Pregnancy Outcome / epidemiology
Substances
Antipsychotic Agents